跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ICATIBANTO PIRAMAL 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ICATIBANTO PIRAMAL 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Approved
STANDARD
ICATIBANTO PIRAMAL 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Piramal Critical Care B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 21, 2022
Approval ID
f73ac948730995eb
Company
Piramal Critical Care B.V.
Type
Standard
Approval Details
Approval Id
f73ac948730995eb
Drug Cima Aemps Name
ICATIBANTO PIRAMAL 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number
86573
Holder Company Name
Piramal Critical Care B.V.
Marketing Company Name
Euromed Pharma Spain S.L.
Holder Company Detail Path
/organization/piramal-critical-care-bv
Authorization Date
2022-02-21
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
30 mg/3 ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Piramal Critical Care B.V.
Company Detail Path
/organization/piramal-critical-care-bv
Company Information
Pharmaceutical Company Name
Piramal Critical Care BV
Country Name
Netherlands
Website
http://www.piramal.com
Active Ingredients
ICATIBANTO ACETATO
35,52 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 21, 2022
Approval ID
f73ac948730995eb
Type
Standard
Back to CIMA-AEMPS Approvals